Research has revealed a connection between severe COVID-19 infections and cancer tumor regression, offering potential new options for cancer treatment. Scientists at the Northwestern Medicine Canning Thoracic Institute discovered that RNA from the SARS-CoV-2 virus can trigger the development of immune cells known as inducible nonclassical monocytes (I-NCMs) with anti-cancer properties. These cells could be used in the treatment of aggressive or advanced cancers that do not respond to traditional therapies. The findings are based on studies of human tissues and animal models, and further research is needed to validate their potential use in clinical trials. This discovery could offer hope for patients with advanced cancers who have exhausted other treatment options.
Source link
Study Links COVID-19 To Tumor Regression, Opens New Venue For Cancer Treatment
